PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 3, 2026Nephrology0 citationsOpen Access

Six‐Weekly Versus Monthly Haemodialysis Blood Testing in an Australian Tertiary Kidney Service: A Quality, Safety, Green Nephrology Initiative and Cost‐Saving Analysis

View Full Paper
DHDaniel HirschGriffith UniversityDGDonia GeorgeWollongong HospitalDPDebbie PughWollongong Hospital

Key Points

  • To evaluate the impact of reducing the frequency of blood tests for haemodialysis patients from monthly to 6-weekly in terms of safety, cost, and environmental benefits.
  • Retrospective evaluation of blood test frequency in 99 patients with monthly testing and 101 with 6-weekly testing.
  • Assessment of hospitalisations, potassium and haemoglobin levels, and cost-savings post-implementation.
  • Survey conducted among dialysis nurses to gather staff perspectives on the practice change.
  • Blood test frequency decreased from 48.3 to 34.9 tests per patient per year after the change.
  • Safety indicators showed no significant increase in hospitalisations or hyperkalaemia between groups.
  • Cost savings of AUD 201.44 in pathology costs and a reduction of 1.03 kg in carbon emissions per patient-year.

Abstract

ABSTRACT There is limited evidence to guide optimal frequency of surveillance bloodwork for haemodialysis patients. In September 2023, surveillance bloodwork frequency was reduced from monthly to 6‐weekly across 4 Illawarra‐Shoalhaven dialysis units. We retrospectively evaluated actual frequency of blood tests, safety (all‐cause hospitalisations, hospitalisations for hyperkalaemia, percentage of potassium and haemoglobin levels in target ranges), cost‐savings and environmental impact (reduction in carbon emissions and waste generation) of 6‐weekly versus monthly scheduled bloodwork for clinically stable patients receiving in‐facility haemodialysis during the 12‐months before and after this practice change. Staff perspectives were gathered via survey. We analysed 99 patients with monthly surveillance bloodwork and 101 patients with 6‐weekly bloodwork. After reducing to 6‐weekly scheduled bloodwork, frequency of FBC/EUC/CMP blood tests decreased from 48. 3 to 34. 9 per patient‐year. Comparing 6‐weekly versus monthly groups, there was no increase in percentage of patients with ≥ 1 hospitalisation (72% vs. 73. 5%, p = 0. 70), hospitalisation for hyperkalaemia (0. 8% vs. 0. 9%, p = 0. 92) ; percentage of patients with potassium levels (3. 5–5. 9 mmol/L) was similar (86. 0% vs. 86. 2%, p = 0. 88). Proportion of haemoglobin levels in target range (100–115 g/L) decreased from 45. 4% to 38. 5% (p < 0. 01) but with no clear changes in Erythropoietin Stimulating Agent use. Overall, there were 3. 8 fewer blood draws, 8. 7 fewer blood tubes used, AUD201. 44 saved in pathology costs and carbon emissions reduced by 1. 03 kg per patient‐year. Of 58 dialysis nurses, 47 (81%) responded to a survey and indicated the practice change was acceptable (38/47, 81%). Reducing surveillance bloodwork frequency to 6‐weekly for haemodialysis patients delivered substantial cost‐savings and had positive environmental benefits without compromising safety. Strong engagement with dialysis staff supports its scalability and sustainability.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Hirsch et al. (2026) studied this question.

synapsesocial.com/papers/69cf5de95a333a821460bfd7https://doi.org/10.1111/nep.70202
Ask AI
Helpful
Bookmark
Share
View Full Paper